Oxygenta Pharmaceutical Ltd

Dematerialisation status

• Details of dematerialised securities for the quarter furnished to stock exchanges.
• Furnishing confirmation received from external registrar.
• Securities dematerialised were mutilated and cancelled; registered owner updated within 15 days.

Oxygenta Pharmaceutical Limited trading window closed from 01 October 2026 until 48 hours after the declaration of Financial Results for the Quarter and Half Year ending 30 September 2026

AGM Details

• Date and time: 21-08-2026, 10:30 AM to 11:15 AM, via VC/OAVM.
• Record date for entitlements: 14-08-2026.

Resolutions

• Resolution 1: Adopt audited standalone financial statements for FY2025-26; passed.
• Resolution 2: Re-appoint Balasubba Reddy Mamilla as director on rotation; passed.
• Resolution 3: Appoint Amireddy Venkatesu Reddy as Whole-time Director; passed.
• Resolution 4: Appoint Janardhana Reddy Yeddula as Independent Director; passed.
• Resolution 5: Approve sale/purchase related party transactions with Virupaksha Organics Limited; passed.
• Resolution 6: Approve loan and guarantee related party transactions with Virupaksha Organics Limited; passed.
• Resolution 7: Ratify cost auditor remuneration for FY2026-27; passed.

Overall outcome

• All seven resolutions were passed; ordinary and special business approved.

AGM Details

• Date and time: 21 August 2026, 10:30 AM IST.
• Mode: Video Conference / AVM.
• Quorum: 75 members attended via VC.
• Record date: 14 August 2026.

Key Resolutions

• Resolution 1 (Ordinary): Adopt audited standalone financial statements for FY2025-26 with reports.
• Resolution 2 (Ordinary): Re-appoint Balasubba Reddy Mamilla as Director.
• Resolution 3 (Special): Appoint Amireddy Venkatesu Reddy as Whole-time Director.
• Resolution 4 (Special): Appoint Janardhana Reddy Yeddula as Independent Director.
• Resolution 5 (Ordinary): Approve material related party sale/purchase with Virupaksha Organics Limited.
• Resolution 6 (Ordinary): Approve material related party loan and guarantee with Virupaksha Organics Limited.
• Resolution 7 (Ordinary): Ratify remuneration to Cost Auditor for FY2026-27.

Voting Results

• All resolutions passed with high in-favor percentages.

Material Related Party Transactions

• Sale and Purchase with Virupaksha Organics Limited approved.
• Loan and Guarantee with Virupaksha Organics Limited approved.

Director Changes

• Amireddy Venkatesu Reddy appointed Whole-time Director.
• Janardhana Reddy Yeddula appointed Independent Director.
• Balasubba Reddy Mamilla re-appointed as Director (rotating).

Auditors

• No changes to statutory auditors announced.

Other Material Approvals

• No other material approvals disclosed.

No AGM details provided in the excerpt for Oxygenta Pharmaceutical Ltd

Financial snapshot

• Revenue from operations: 11,298.19 Lakh in 2025-26, up from 10,929.86.
• Net loss after tax: 1,757.17 Lakh in 2025-26, vs 1,029.83.
• Total comprehensive income: 52.54 Lakh in 2025-26; prior year (−10.73).
• EPS: -4.75 per share for 2025-26.
• Equity negative at (4,268.68) Lakh; gearing -2.52x.
• Total borrowings: 10,956.68 Lakh; cash & cash equivalents: 41.90 Lakh.
• No breaches in debt covenants.
• India revenue: 11,296.73 Lakh; export: 1.46.
• Dividend: no dividend declared for 2025-26.

Business & geography

• Single operating segment: Pharmaceuticals.
• Geography: India revenue 11,296.73; Export 1.46.
• Non-current assets in India: 4,634.41.
• Major customer Virupaksha Organics Limited contributed 7,216.06 (63.87%) of revenue.

Capital structure & liquidity

• Equity capital: 3,698.35; total equity: (4,268.68).
• Borrowings: Non-current 7,528.60; current 3,428.08; total 10,956.68.
• Net debt: 10,741.77; cash & bank balances: 173.00; cash equivalents: 41.90.
• Gearing ratio: −2.52x; no covenant breaches.

Related party transactions

• Holding company Virupaksha Organics Limited holds 56.50% equity.
• FY2025-26 VOL RPTs: Sales 6,665.37; Purchases 6,275.55; Inter‑company borrowings 3,550.00; Interest 169.34; Total 16,660.27.
• FY2026-27 proposed RPTs with VOL: Inter‑corporate borrowing 10,000; Guarantees 10,000; Total 20,000.
• RPTs approved by Audit Committee; ordinary course and arm's length; related-party voting restrictions apply.

Governance & leadership changes

• Amireddy Venkatesu Reddy appointed Whole-Time Director for 3 years from 23-05-2026; remuneration Rs 6-8 LPM.
• Janardhana Reddy Yeddula appointed Independent Director for 5 years from 23-05-2026.
• CFO Prasad Reddy Battinapatla appointed 07-11-2025.
• CS Kumkum Bajaj appointed 14-08-2025; Dolly Mandhan resigned 14-08-2025.
• Promoter group reclassification: VOL became promoter; post open offer.
• Board size six: three independent, three executive, one non-exec.

Audit & risk management

• Statutory auditors AM Reddy & D.R. Reddy; unmodified opinion.
• Secretarial Auditor Aakanksha Dubey & Co; no qualifications.
• Internal Audit: Suryachandra & Associates; reappointed for 2026-27.
• Going concern: material uncertainty due to negative net worth; VOL support and revival plan; Rs 2000 Lakh bank facility; expected EBITDA positive in FY27.

Risks & outlook

• Customer concentration risk: VOL accounted for 63.87% of revenue.
• Deferred tax asset: 1740.74 Lakh; realization depends on future profitability.
• ECL on trade receivables: 130.09 Lakh; VOL as major debtor.
• API industry risks: raw material costs, regulation, currency and supply-chain disruptors.
• Outlook: revival plan underway; promoter support expected to restore profitability.

CSR & sustainability

• CSR not applicable; company voluntarily contributed Rs 4.30 Lakh.
• Green initiatives: e-communication with shareholders.
• Climate-related disclosures and risk monitoring noted in Annexure V.

AGM Details

• Date and time: 21 August 2026 at 10:30 A.M.
• Mode: Video Conferencing / Other Audio Visual Means
• Record/Book closure: 15.08.2026 to 21.08.2026
• Remote e-voting: 18-20 Aug 2026; cut-off: 14 Aug 2026

Resolutions Put to Vote

• Ordinary: Adopt Audited Financial Statements for year ended 31 March 2026
• Ordinary: Re-appoint Balasubba Reddy Mamilla as Director by rotation
• Special: Appoint Amireddy Venkatesu Reddy as Director and Whole Time Director for 3 years with remuneration Rs 6-8 lakh/month
• Special: Appoint Janardhana Reddy Yeddula as Independent Director for five years
• Ordinary: Approve material RPT with VOL for sale/purchase up to Rs 250 Cr
• Ordinary: Approve material RPT (loan and guarantees) with VOL up to Rs 200 Cr
• Ordinary: Ratify Cost Auditor remuneration for FY 2026-27

Voting Results

• Final results not disclosed here; to be announced at AGM and posted on BSE and e-voting portal

Dividend

• Dividend: No dividend proposed or declared for the year 2025-26

Director Changes

• Board changes since 2025 include resignations and new appointments amid open offer
• Resignations: six directors on 20.06.2025; two more on 18.08.2025
• Appointments: multiple directors added on 20.06.2025; Amireddy Venkatesu Reddy and Janardhana Reddy Yeddula appointed 23.05.2026

Auditors

• Statutory auditors: A.M. Reddy & D.R. Reddy; tenure to 2027-28; remuneration approx Rs 8.5 L
• Secretarial auditors: Aakanksha Dubey & Co; 5-year term (2025-2030)
• Internal auditors: Suryachandra & Associates; appointed for 2026-27
• Cost auditors: PCR & Associates; remuneration Rs 75,000; for 2026-27

Material Related Party Transactions

• Holding Company VOL is promoter; RPTs include sale/purchase up to Rs 250 Cr and loans/guarantees up to Rs 200 Cr

Other material approvals

• Open offer details and related party disclosures are covered in the accompanying statements

Cost Auditor Appointment

• Appointed M/s. PCR & Associates, Cost Accountants, as Cost Auditors for FY 2026-27.
• Date of appointment: 27 July 2026; term for FY 2026-27; subject to shareholders' ratification.
• Profile: PCR & Associates is a leading cost accounting firm offering cost audit and related services.
• Disclosure: Not Applicable; no director relationships disclosed.

POSH Committee Reconstitution

• Re-constituted the POSH Committee of the Board with effect from 27 July 2026.
• Presiding Officer: Ms. Kurapati Divya; Internal Members: Jyothi Kuchipudi, B. Rajitha, S. Chandraleka, Yempally Sindhu.
• External Member: Ms. D. Rajeswari.

Board meeting reschedule details

• Postponed from 25 July 2026 to 27 July 2026.
• Agenda includes unaudited quarterly results for quarter ended 30 June 2026 and related limited review.
• Other business with chair's permission.

Dematerialisation processing status

• RTA confirmed dematerialisation during the quarter was processed and details furnished to all stock exchanges.
• Physical certificates for dematerialisation were mutilated and cancelled after verification; depositories updated as registered owner within 15 days.